LFA-1 INHIBITOR FORMULATIONS

LFA-1 INHIBITOR FORMULATIONS

The present invention provides formulations, methods and kits for the treatment of dry eye diseases. In particular, stabilized pharmaceutical compositions comprising the compound of Formula 1 are described herein for a variety of uses including the treatment of dry eye syndrome. In one aspect, metho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NEWMAN, Mary, HUNKE, William
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator NEWMAN, Mary
HUNKE, William
description The present invention provides formulations, methods and kits for the treatment of dry eye diseases. In particular, stabilized pharmaceutical compositions comprising the compound of Formula 1 are described herein for a variety of uses including the treatment of dry eye syndrome. In one aspect, methods and ingredients for improving the stability of compositions of the compound of Formula 1 are described.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA201608069B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA201608069B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA201608069B3</originalsourceid><addsrcrecordid>eNrjZJDxcXPUNVTw9PPwdPIM8Q9ScPMP8g31cQzx9PcL5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8VGORgaGZgYWBmaWTsbEqAEAapkg1Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LFA-1 INHIBITOR FORMULATIONS</title><source>esp@cenet</source><creator>NEWMAN, Mary ; HUNKE, William</creator><creatorcontrib>NEWMAN, Mary ; HUNKE, William</creatorcontrib><description>The present invention provides formulations, methods and kits for the treatment of dry eye diseases. In particular, stabilized pharmaceutical compositions comprising the compound of Formula 1 are described herein for a variety of uses including the treatment of dry eye syndrome. In one aspect, methods and ingredients for improving the stability of compositions of the compound of Formula 1 are described.</description><language>eng</language><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171129&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201608069B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171129&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201608069B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NEWMAN, Mary</creatorcontrib><creatorcontrib>HUNKE, William</creatorcontrib><title>LFA-1 INHIBITOR FORMULATIONS</title><description>The present invention provides formulations, methods and kits for the treatment of dry eye diseases. In particular, stabilized pharmaceutical compositions comprising the compound of Formula 1 are described herein for a variety of uses including the treatment of dry eye syndrome. In one aspect, methods and ingredients for improving the stability of compositions of the compound of Formula 1 are described.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDxcXPUNVTw9PPwdPIM8Q9ScPMP8g31cQzx9PcL5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8VGORgaGZgYWBmaWTsbEqAEAapkg1Q</recordid><startdate>20171129</startdate><enddate>20171129</enddate><creator>NEWMAN, Mary</creator><creator>HUNKE, William</creator><scope>EVB</scope></search><sort><creationdate>20171129</creationdate><title>LFA-1 INHIBITOR FORMULATIONS</title><author>NEWMAN, Mary ; HUNKE, William</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA201608069B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>online_resources</toplevel><creatorcontrib>NEWMAN, Mary</creatorcontrib><creatorcontrib>HUNKE, William</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NEWMAN, Mary</au><au>HUNKE, William</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LFA-1 INHIBITOR FORMULATIONS</title><date>2017-11-29</date><risdate>2017</risdate><abstract>The present invention provides formulations, methods and kits for the treatment of dry eye diseases. In particular, stabilized pharmaceutical compositions comprising the compound of Formula 1 are described herein for a variety of uses including the treatment of dry eye syndrome. In one aspect, methods and ingredients for improving the stability of compositions of the compound of Formula 1 are described.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_ZA201608069B
source esp@cenet
title LFA-1 INHIBITOR FORMULATIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T16%3A56%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NEWMAN,%20Mary&rft.date=2017-11-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA201608069B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true